Der Schmerz
-
The regular update of the guidelines on fibromyalgia syndrome, AWMF number 145/004, was scheduled for April 2017. ⋯ Amitriptyline and duloxetine are recommended in the case of comorbid depressive disorders or generalized anxiety disorder and pregabalin in the case of generalized anxiety disorder. Off-label use of duloxetine and pregabalin can be considered if there are no comorbid mental disorders or no generalized anxiety disorder. Strong opioids are not recommended.
-
The regular update of the guidelines on fibromyalgia syndrome, AWMF number 145/004, was scheduled for April 2017. ⋯ No consensus was achieved in the guideline group on whether the diagnostic label "juvenile fibromyalgia" should be used in the management of children and adolescents with chronic widespread pain. There was consensus in the guideline group that antidepressants and anticonvulsants should not be used to treat pain in the so-called juvenile fibromyalgia syndrome.
-
The regular update of the guidelines on fibromyalgia syndrome, AWMF number 145/004, was scheduled for April 2017. ⋯ The diagnosis of fibromyalgia syndrome should be explicitly communicated to the affected individual. Shared decision-making with the patient on the therapeutic options based on individual preferences of the patient, comorbidities and the success of previous treatment is recommended. A step-wise treatment approach depending on the severity of fibromyalgia syndrome and the response to therapeutic measures is recommended.
-
The regular update of the guidelines on fibromyalgia syndrome, AWMF number 145/004, was scheduled for April 2017. ⋯ Low to moderate intensity endurance and strength training are strongly recommended. Chiropractic, laser therapy, magnetic field therapy, massage and transcranial magnetic stimulation are not recommended.